← Evidence map

ArticleOncotarget2018

Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells.

Kamil Lisek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

81 papers cite itlatest 60 shown

2018
…
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29755668